Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 30;28(1):28-42.
doi: 10.5056/jnm21221.

Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea

Affiliations
Review

Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea

Tae-Geun Gweon et al. J Neurogastroenterol Motil. .

Abstract

Fecal microbiota transplantation (FMT) is a highly efficacious and safe modality for the treatment of recurrent or refractory Clostridioides difficile infection (CDI), with overall success rates of 90%. Thus, FMT has been widely used for 10 years. The incidence and clinical characteristics of CDI, the main indication for FMT, differ between countries. To date, several guidelines have been published. However, most of them were published in Western countries and therefore cannot represent the Korean national healthcare systems. One of the barriers to performing FMT is a lack of national guidelines. Accordingly, multidisciplinary experts in this field have developed practical guidelines for FMT. The purpose of these guidelines is to aid physicians performing FMT, which can be adapted to treat CDI and other conditions.

Keywords: Fecal microbiota transplantation; Guideline; Treatment.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None.

Figures

Figure
Figure
Forest plot of studies comparing frozen stool with fresh stool for fecal microbiota transplantation. M-H, Mantel-Haenszel.

References

    1. Quraishi MN, Widlak M, Bhala N, et al. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Aliment Pharmacol Ther. 2017;46:479–493. doi: 10.1111/apt.14201. - DOI - PubMed
    1. Cammarota G, Ianiro G, Tilg H, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017;66:569–580. doi: 10.1136/gutjnl-2016-313017. - DOI - PMC - PubMed
    1. Mullish BH, Quraishi MN, Segal JP, et al. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut. 2018;67:1920–1941. doi: 10.1136/gutjnl-2018-316818. - DOI - PubMed
    1. Cammarota G, Ianiro G, Kelly CR, et al. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut. 2019;68:2111–2121. doi: 10.1136/gutjnl-2019-319548. - DOI - PMC - PubMed
    1. Ng SC, Kamm MA, Yeoh YK, et al. Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE) Gut. 2020;69:83–91. doi: 10.1136/gutjnl-2019-319407. - DOI - PMC - PubMed

LinkOut - more resources